US Pharma MarketingImmunology specialist Khartis Therapeutics emerges from stealth with $95m
Immunology specialist Khartis Therapeutics emerges from stealth with $95m is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.
Source: Pharmaceutical Technology